Biofilm-Associated Multi-Drug Resistance in Hospital-Acquired Infections: A Review
Muluneh Assefa,Azanaw Amare
DOI: https://doi.org/10.2147/IDR.S379502
2022-08-31
Infection and Drug Resistance
Abstract:Muluneh Assefa, Azanaw Amare Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia Correspondence: Muluneh Assefa, Tel +251945572632, Email Biofilm-related multi-drug resistance (MDR) is a major problem in hospital-acquired infections (HAIs) that increase patient morbidity and mortality rates and economic burdens such as high healthcare costs and prolonged hospital stay. This review focuses on the burden of bacterial biofilm in the hospital settings, their impact on the emergence of MDR in the HAIs, biofilm detection methods, recent approaches against biofilms, and future perspectives. The prevalence of biofilm-associated MDR among HAIs ranges from 17.9% to 100.0% worldwide. The predominant bacterial isolates causing HAIs in recently published studies were S. aureus , A. baumannii, K. pneumoniae , and P. aeruginosa . In addition to the use of qualitative and quantitative methods to detect biofilm formation, advanced PCR-based techniques have been performed for detecting biofilm-associated genes. Although there are suggested therapeutic strategies against biofilms, further confirmation of their efficacy for in vivo application and antibiotics targeting biofilm-associated genes/proteins to minimize treatment failure is required for the future. Keywords: biofilm, multi-drug resistance, hospital-acquired infections Biofilm is an aggregate of microorganisms embedded within a self-produced substance or extracellular polymeric matrix and is irreversibly attached to living or non-living surfaces, and it is a useful adaptation of microorganisms, enabling them to survive in certain environments. 1,2 Biofilm formation is a sequential and multi-stage phenomenon that includes the attachment of free-floating microorganisms to a surface, microcolony formation or cell growth, maturation or development, and dispersion that enables biofilms to spread and colonize new surfaces. 3 Globally, biofilm-associated infections are more prevalent in the hospital settings owing to their recalcitrant nature and difficulty in treatment. Biofilms are estimated to be responsible for more than 65% of nosocomial infections, approximately 80% of chronic infections, and 60% of all human bacterial infections. 4,5 Biofilm-related diseases increase the morbidity and mortality rates of patients and economic burdens such as high healthcare costs and prolonged patient stays. 6 Biofilms play an important role in facilitating the emergence of antimicrobial resistance, generating chronic infections, modulation of host immune response, contamination of medical devices, and existence in the hospital effluents, which are frequent reservoirs of drug-resistant genes. 7 The formation of biofilms is associated with factors such as the microbial density and type of organisms to which the device is exposed, the duration of device use, presence of essential nutrients, nature of the device, the concentration of drug, environment, and expression of biofilm-associated genes. 8,9 Bacterial biofilms in hospitals can be formed in the hospital wastewater, high-touch solid surfaces, left-over drugs, and medical instruments, causing the common hospital-acquired infections (HAIs) such as ventilator-associated pneumonia (VAP), surgical site infections (SSIs), catheter-associated urinary tract infections (CA-UTI), and bloodstream infections (BSIs). 10 Both Gram-positive and Gram-negative bacteria can cause HAIs, with the most prevalent biofilm-forming bacteria being methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis , Viridans Streptococci, Enterococcus faecalis , Vancomycin-resistant Enterococci (VRE), Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Proteus mirabilis, and Klebsiella pneumoniae (Figure 1). 11,12 Figure 1 The link between biofilm-hospital-infection. Abbreviations : HCWs, healthcare workers; UTI, urinary tract infection; MRSA, methicillin-resistant Staphylococcus aureus ; VRE, vancomycin-resistant Enterococci. Biofilms aid microbes to easily adhere to indwelling medical devices (IMDs) such as contact lenses, central venous catheters, mechanical heart valves, peritoneal dialysis catheters, prosthetic joints, pacemakers, urinary catheters, voice prostheses, intravascular catheters, dental inserts, breast implants, and orthopedic inserts are a potential risk of drug-resistant pathogens for patients following these devices. 13,14 Biofilms in the endotracheal tubes of mechanically ventilated patients act as a protective shield against host immunity and can induce chronic and recurrent infections that resist commonly p -Abstract Truncated-
pharmacology & pharmacy,infectious diseases